연구성과로 돌아가기

2024 연구성과별 연구자 정보 (1643 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Powles, Thomas Powles, T 1 교신저자 Queen Mary Univ London, Barts Hlth NHS Trust Biomed Res Ctr, Barts Canc Inst, London, England AER-4585-2022 Powles, Thomas thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Catto, James W. F. Catto, JWF 2 Univ Sheffield, Sch Med & Populat Hlth, Div Clin Med, Sheffield, S Yorkshire, England thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Catto, James W. F. Catto, JWF 2 Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Galsky, Matthew D. Galsky, MD 3 Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, New York, NY 10029 USA thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Al-Ahmadie, Hikmat Al-Ahmadie, H 4 Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, 1275 York Ave, New York, NY 10021 USA 0000-0002-2938-6627 Al-Ahmadie, Hikmat thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Meeks, Joshua J. Meeks, JJ 5 Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Meeks, Joshua J. Meeks, JJ 5 Northwestern Univ, Dept Biochem, Feinberg Sch Med, Chicago, IL 60611 USA thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Nishiyama, Hiroyuki Nishiyama, H 6 Univ Tsukuba, Tsukuba, Ibaraki, Japan thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Vu, Toan Quang Vu, TQ 7 Vietnam Natl Canc Hosp, Internal Med 3, Hanoi, Vietnam thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Antonuzzo, Lorenzo Antonuzzo, L 8 Univ Florence, Dept Expt & Clin Med, Florence, Italy thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Antonuzzo, Lorenzo Antonuzzo, L 8 Careggi Univ Hosp, Med Oncol Unit, Florence, Italy thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Wiechno, Pawel Wiechno, P 9 Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Atduev, Vagif Atduev, V 10 Fed Med Biol Agcy, Volga Dist Med Ctr, Nizhnii Novgorod, Russia V-3467-2017 Atduev, Vagf 0000-0003-4478-7282 Atduev, Vagif thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Kann, Ariel G. Kann, AG 11 Hosp Alemao Oswaldo Cruz, Sao Paulo, Brazil thomas.powles1@nhs.net;
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Kim, Tae-Hwan Kim, TH 12 Kyungpook Natl Univ, Chilgok Hosp, Dept Urol, Daegu, South Korea M-3962-2017 Kim, Tae-Hwan thomas.powles1@nhs.net;
페이지 이동: